NSEUpdates19 Jun 2026 · 19 Jun 2026, 07:42 pm

Updates

Bliss GVS Pharma Limited · BLISSGVS

✦ AI Summary

Bliss GVS Pharma Limited has informed the exchanges about a communication sent to its shareholders regarding the tax deduction on dividend income. Following the Finance Act, 2020, dividend distribution tax has been abolished, and dividend income is now taxable directly in the hands of shareholders. The company has emailed shareholders with registered IDs, explaining the new tax deduction process. This communication details the formalities shareholders must follow to ensure appropriate tax deduction on any dividend declared at the 41st Annual General Meeting for FY 2026-2027. Investors should review this information to understand their tax obligations for future dividend payouts.

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bliss GVS Pharma Limited has informed the Exchange regarding 'the communication sent to shareholders regarding Intimation of Tax Deduction on Dividend.'.

Attachments (1)

📄

BLISSGVS_19062026194111_Intimation_of_TDS_Communication.pdf

pdf

Download →
View document text
June 19, 2026 To To The Manager, Listing Department The General Manager, Listing Department National Stock Exchange of India BSE Limited Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai- 400 051 Mumbai- 400 001 Symbol: BLISSGVS Scrip Code: 506197 Subject: Communication to Shareholders - Intimation of Tax Deduction on Dividend Dear Sir/Madam, Pursuant to the Income Tax Act, 1961, as amended by the Finance Act, 2020, dividend distribution tax has been abolished, and dividend income is taxable in the hands of the shareholders. In this regard, please find enclosed herewith an email communication sent to all shareholders having their email IDs registered with the Company/Depositories explaining the process regarding the applicability of tax deduction and formalities to be followed by the shareholders to ensure appropriate deduction of tax on the dividend, if declared at the 41st Annual General Meeting and payable during FY 2026-2027. This communication is also being made available on the website of the Company at https://www.blissgvs.com/tds-on-dividend This is for your information and records. Yours faithfully, For Bliss GVS Pharma Limited Aditi Bhatt Company Secretary & Compliance Officer Encl: As above BLISS GVS PHARMA LIMITED Corporate Identity Number (CIN): L24230MH1984PLC034771 Registered Office: 102, Hyde Park, Saki Vihar Road, Saki Naka, Andheri (East), Mumbai - 400 072. Tel: 022-42160000 Fax: 022-28563930 Website: www.blissgvs.com; E-mail: info@blissgvs.com / cs@blissgvs.com June 19, 2026 TDS COMMUNICATION Dear Shareholder, Trust you and your family are safe and in good health. We are pleased to inform you that the Board of Directors of the Company at their Meeting held on Tuesday, May 12, 2026, has recommended a Final Dividend of Re. 1.00/- paise per equity share having a face value of Re. 1/- for the Financial Year ended March 31, 2026, and the said Final Dividend will be payable post approval of the shareholders at the ensuing 41st Annual General Meeting (“AGM”) of the Company to be held on Wednesday, July 15, 2026. As per the Income Tax Act, 2025 (the Act), dividends paid or distributed by the Company are taxable in the hands of the shareholders. The Company shall therefore be required to deduct tax at source (TDS) at the time of making the payment of the said Dividend if approved at the aforesaid AGM. Please note that the Company has fixed Wednesday, July 08, 2026, as the record date for identification and determining the eligibility of shareholders to whom the final dividend will be paid. Shareholders are requested to ensure that their bank account details in their respective demat accounts/physical folios are updated, to enable the Company to make timely credit of dividends in their bank accounts. The tax deduction rates would vary depending on the residential status of the shareholders, documents submitted by the shareholders and accepted by the Company. This communication provides a brief of the applicable Tax Deduction at Source (TDS) provisions under the Act for Resident and Non-Resident shareholder categories. FOR RESIDENT SHAREHOLDERS Tax is required to be deducted at source under Section 393(1) read with 393(4) of the Act, at the rate of 10% on the amount of dividend where shareholders have registered their valid Permanent Account Number (PAN). In case shareholders do not have a PAN / invalid PAN/ PAN not linked with Aadhar, TDS at the rate of 20% shall be deducted under Section 397(2) of the Act. A.Resident Individuals: No tax shall be deducted on the dividend payable to resident individuals if: i. The total dividend amount to be received by them during the Tax Year (TY) 2026- 27 does not exceed Rs. 10,000/-; or ii. The shareholder provides Form 121 (applicable to all individuals irrespective of the age) provided that all the required eligibility conditions are met. Please note that all fields are mandatory to be filled up and the Company may at its sole discretion, reject the form if it does not fulfill the prescribed requirement under the Act. The template of Form 121 is enclosed as Annexure 1. iii. An exemption certificate is issued by the Income-tax Department, if any. B. Resident Non-Individuals: No tax shall be deducted on the dividend payable to the following resident non-individuals where they provide details and documents as per the format attached in Annexure 2. i. Insurance Companies: Self-declaration that it qualifies as an ‘Insurer’ as per section 2(7A) of the Insurance Act, 1938, and has full beneficial interest with respect to the equity shares owned by it along with a self-attested copy of PAN card and certificate of registration with Insurance Regulatory and Development Authority (IRDA)/ LIC/ GIC. ii. Mutual Funds: Self-declaration that it is registered with SEBI and as specified under Schedule VII to section 11 of the Act along with a self-attested copy of PAN card and certificate of registration with SEBI. iii. Alternative Investment Fund (AIF): Self-declaration that its income is exempt under Schedule V to section 11 of the Act, and they are registered with SEBI as Category I or Category II AIF along with a self-attested copy of the PAN card and certificate of AIF registration with SEBI. iv. New Pension System (NPS) Trust: Self-declaration that it qualifies as an NPS trust and income is eligible for exemption under Schedule VII to section 11 of the Act, and being regulated by the provisions of the Indian Trusts Act, 1882 along with a self- attested copy of the PAN card. v. Other Non-Individual shareholders: Self-attested copy of documentary evidence supporting the exemption along with a self-attested copy of PAN card. C. In case, shareholders (both individuals or non-individuals) provide a certificate under 395(1) of the Act, for lower / NIL withholding of taxes, the rate specified in the said certificate shall be considered, on submission of a self-attested copy to the company. Note: Recording of the PAN for the registered Folio/DP ID-Client ID is mandatory. In the absence of valid PAN, tax will be deducted at a higher rate of 20%, under Section 397(2) of the Act. FOR NON-RESIDENT SHAREHOLDERS As per the Domestic Tax Law Taxes are required to be withheld in accordance with the provisions of Section 393(2) of the Act , as per the rates applicable. As per the relevant provisions of the Act, the withholding tax shall be at the rate of 20% (plus applicable surcharge and cess) on the amount of dividend payable to them. In case non-resident shareholders provide a certificate issued under Section 395(1) of the Act, for lower/ Nil withholding of taxes, the rate specified in the said certificate shall be considered, on submission of a self-attested copy of the same. As per the Double Tax Avoidance Agreement (DTAA) i. Any Non-resident shareholder, Foreign Institutional Investors, Foreign Portfolio Investors (FII, FPI): As per Section 159 of the Act, the non-resident shareholder, including Foreign Institutional Investors and Foreign Portfolio Investors, has the option to be governed by the provisions of the DTAA between India and the country of tax residence of the shareholder, if they are more beneficial to them. For this purpose, i.e., to avail DTAA benefits, the non-resident shareholders are required to submit the following: a. Self-attested copy of the PAN card allotted, if any, by the Indian Income Tax authorities. b. Self-attested copy of Tax Residency Certificate (TRC) for the tax year April 1, 2026, to March 31, 2027, or calendar year 2026, valid as on record date, obtained from the tax authorities of the country of which the shareholder is a resident. c. Shareholders need to mandatorily provide digital Form 41 covering the period from April 1, 2026, to March 31, 2027 (Refer Annexure 3 for procedure to file electronic Form d. In case of Foreign Institutional Investors and Foreign Portfolio Investors, a copy of the SEBI registration certificate. e. Self [Showing first 8,000 characters — download PDF for full document]